Washington, D.C., January 10, 2011 The American Association for Clinical Chemistry (AACC) announces a webinar, Novel Biomarkers for the Diagnosis and Management of Diabetes, to be held on February 24, 2011, at 2:00 pm Eastern. The webinar will last 90 minutes.
It is estimated that more than 42 million Americans, of whom 40 percent remain undiagnosed, now have diabetes. Detection and management of the disease is one of the greatest health challenges facing the US today, and as researchers learn more about its pathophysiology they are making progress in a number of areas of diabetes research, including many that will affect laboratorians and potentially change clinical laboratory practice. In order to promote awareness of these recent advances, as well as the controversies that remain, the February 2011 issue of AACC’s flagship journal Clinical Chemistry is devoted entirely to diabetes. The webinar has been designed to complement the information in Clinical Chemistry.
The expert panel for the webinar features three of the diabetes issue’s contributing authors who will provide additional information on biomarkers:
David B. Sacks, MB, ChB, FACP, Senior Investigator and Chief of the Clinical Chemistry Service, Department of Laboratory Medicine, the National Institutes of Health, Bethesda, MD;
Allison B. Goldfine, MD, Associate Professor of Medicine, Department of Medicine, Harvard University, and Head of Clinical Research, Joslin Diabetes Center, Boston, MA;
William E. Winter, MD, Professor in the Departments of Pathology, Immunology, and Laboratory Medicine; Pediatrics; and Molecular Genetics and Microbiology, University of Florida College of Medicine, Gainesville, FL.
AACC invites journalists covering this major healthcare issue to register for this important webinar. For a complimentary registration, complete and submit a Press Registration Form. For more information, or a complimentary copy of the February issue of Clinical Chemistry, contact Peter Patterson on either of the above phone numbers or at firstname.lastname@example.org.